RTNXF (Renalytix) Price-to-Tangible-Book : (As of Dec. 12, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Renalytix Price-to-Tangible-Book?

As of today (2024-12-12), Renalytix's share price is $0.08. Renalytix's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was $-0.07. Hence, Renalytix's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Renalytix's Price-to-Tangible-Book or its related term are showing as below:

During the past 7 years, Renalytix's highest Price to Tangible Book Ratio was 24.00. The lowest was 2.66. And the median was 10.24.

RTNXF's Price-to-Tangible-Book is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 3.03
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Renalytix's share price is $0.08. Renalytix's Book Value per Sharefor the quarter that ended in Sep. 2024 was $-0.07. Hence, Renalytix's P/B Ratio of today is .

Renalytix Price-to-Tangible-Book Historical Data

The historical data trend for Renalytix's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Price-to-Tangible-Book Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Price-to-Tangible-Book

Get a 7-Day Free Trial

21.29

14.29

8.83

Renalytix Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Renalytix's Price-to-Tangible-Book

For the Health Information Services subindustry, Renalytix's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renalytix's Price-to-Tangible-Book Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Renalytix's Price-to-Tangible-Book falls into.

Renalytix Price-to-Tangible-Book Calculation

Renalytix's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2024 )
	=	0.08	/	-0.068
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Renalytix Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Renalytix's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (OTCPK:RTNXF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

RNLXY:USA RENX:UK 2O9A:Germany

Address

2 Leman Street, London, GBR, E1W 9US

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.